Literature DB >> 15010698

Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.

Diana Martinez1, Allegra Broft, Richard W Foltin, Mark Slifstein, Dah-Ren Hwang, Yiyun Huang, Audrey Perez, W Gordon Frankle, Thomas Cooper, Herbert D Kleber, Marian W Fischman, Marc Laruelle, W Gordon Frankel.   

Abstract

Striatal dopamine D2 receptors have been implicated in the neurobiology of cocaine addiction. Previous imaging studies showed reduced striatal D2 receptor availability in chronic cocaine abusers, and animal studies suggested that low D2 receptor availability promotes cocaine self-administration. Here, D2 receptor availability was assessed with positron emission tomography (PET) and [11C]raclopride in the limbic, associative, and sensori-motor subdivisions of the striatum in 17 recently detoxified chronic cocaine-dependent (CCD) subjects and 17 matched healthy control (HC) subjects. In addition, the relationship between regional D2 receptor availability and behavioral measures obtained in cocaine self-administration sessions was investigated in CCD subjects. [11C]Raclopride binding potential was significantly reduced by 15.2% in the limbic striatum, 15.0% in the associative striatum, and 17.1% in the sensori-motor striatum in CCD subjects compared to HC subjects. In CCD subjects, no relationship was detected between D2 availability in striatal regions and either the positive effects of smoked cocaine or the choice of cocaine over an alternative reinforcer (money) following a priming dose of cocaine (a laboratory model of relapse). Thus, this study confirms previous reports of a modest decrease in D2 receptor availability in CCD subjects, and establishes that this decrease is generalized throughout the striatum. However, this study failed to demonstrate a relationship between D2 receptor availability and cocaine-induced cocaine-taking behavior. Additional research is warranted to unravel potential neurobiological traits that might confer vulnerability to relapse in detoxified CCD subjects. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010698     DOI: 10.1038/sj.npp.1300420

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  122 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.

Authors:  Isabelle Boileau; Doris Payer; Sylvain Houle; Arian Behzadi; Pablo M Rusjan; Junchao Tong; Diana Wilkins; Peter Selby; Tony P George; Martin Zack; Yoshiaki Furukawa; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

3.  Striatal dopamine type 2 receptor availability in anorexia nervosa.

Authors:  Allegra Broft; Mark Slifstein; Joseph Osborne; Paresh Kothari; Simon Morim; Rebecca Shingleton; Lindsay Kenney; Shankar Vallabhajosula; Evelyn Attia; Diana Martinez; B Timothy Walsh
Journal:  Psychiatry Res       Date:  2015-07-26       Impact factor: 3.222

4.  Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.

Authors:  Osnat Ben-Shahar; Patrick Keeley; Mariana Cook; Wayne Brake; Megan Joyce; Myriel Nyffeler; Rebecca Heston; Aaron Ettenberg
Journal:  Brain Res       Date:  2006-12-11       Impact factor: 3.252

5.  Cardiovascular and Subjective Effects of the Novel Adenosine A(2A) Receptor Antagonist SYN115 in Cocaine Dependent Individuals.

Authors:  Sd Lane; Ce Green; Jl Steinberg; L Ma; Jm Schmitz; N Rathnayaka; Sd Bandak; S Ferre; Fg Moeller
Journal:  J Addict Res Ther       Date:  2012-03-28

Review 6.  Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Authors:  Scott Mackey; Martin Paulus
Journal:  Neurosci Biobehav Rev       Date:  2012-12-17       Impact factor: 8.989

Review 7.  The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction.

Authors:  Jon Morgenstern; Nasir H Naqvi; Robert Debellis; Hans C Breiter
Journal:  Psychol Addict Behav       Date:  2013-04-15

Review 8.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

9.  Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study.

Authors:  Bret R Rutherford; Jongwoo Choi; Mark Slifstein; Kaleigh O'Boyle; Anissa Abi-Dargham; Patrick J Brown; Melanie W Wall; Nora Vanegas-Arroyave; Jayant Sakhardande; Yaakov Stern; Steven P Roose
Journal:  J Affect Disord       Date:  2020-01-15       Impact factor: 4.839

Review 10.  Emerging association between addictive gaming and attention-deficit/hyperactivity disorder.

Authors:  Aviv Weinstein; Abraham Weizman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.